Abbott Laboratories (ABT) Q1 2022 Earnings Results

Abbott Laboratories Beats on EPS, Stock Up 2.22%

Abbott Laboratories reported a strong earnings per share, exceeding expectations by nearly 18%. The stock reacted positively, rising by 2.22%. However, without revenue data or management commentary, it’s difficult to assess the overall performance and future outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.73	N/A	+17.77%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Abbott Laboratories Beats on EPS, Stock Up 2.22%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Laboratories Beats on EPS, Stock Up 2.22%

Key numbers

Management commentary